US FDA approves use of Tafinlar & Mekinist together to treat BRAF-positive anaplastic thyroid cancer

US FDA approves use of Tafinlar & Mekinist together to treat BRAF-positive anaplastic thyroid cancer  pharmabiz.com FDA Approves Combo Therapy for BRAF-Positive Anaplastic Thyroid Cancer  Specialty Pharmacy Times Combo Therapy OK'd for Aggressive Thyroid Cancer  NewsmaxFull coverage

Read More ...
US FDA approves use of Tafinlar & Mekinist together to treat BRAF-positive anaplastic thyroid cancer published May 07, 2018 at 12:33PM. Original Source Link : http://www.pharmabiz.com/NewsDetails.aspx?aid=108704&sid=2

loading...